By ...
July 13, 2017
3D Printing – ANVISA orders shutdown of production line of customized prostheses
The operation confirmed that prostheses were manufactured on demand of two companies, which may be subject to penalties including a fine that may reach the maximum amount of R$ 1.5 million. This fine can also be cumulative with shutdown and cancellation of permits and licenses to operate. As a follow-up, after the investigation of one of the companies, on 07/11/2017, ANVISA seized 60 illegal prostheses that lacked the mandatory documentation concerning its traceability. Moreover, there is evidence that some public documents could have been altered.
Despite Senai Joinville´s reputation with research related with 3D printing, also known as “additive manufacture”, the current episode demonstrates that regulatory compliance should be carefully dealt by research centers, even with the absence of specific regulation.
Last by ...
October 23, 2020
Pharma & Medical Device Regulation in Brazil
Our partner and Head of Regulatory Anderson Ribeiro, together with his associates Lucas Calabria and Matheus Montecasciano, co-sign the chapter “Pharma & … Pharma & Medical Device Regulation in Brazil
July 13, 2017
3D Printing – ANVISA orders shutdown of production line of customized prostheses
ANVISA has informed in its website, on 07/04/2017, the undertake of an operation that determined the shutdown, for at least 30 days, of a manufacturing line of personalized face and skull prostheses.
According to ANVISA, the Senai Joinville (a branch of the National Industrial Apprentice Service) has been manufacturing customized prostheses without authorization of the regulatory agency.